AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesNCT05519345

Operant Conditioning After ACL Reconstruction

A study testing Operant Conditioning in people with Anterior Cruciate Ligament Injuries, run by University of Michigan at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to examine if the changes in corticospinal function that accompany ACL reconstruction can be improved through a form of mental coaching and encouragement, known as operant conditioning. Read more about this study

Who is it for?
Ages 14 to 45 years
Conditions the study is for
Anterior Cruciate Ligament Injuries
What is being tested?
Operant Conditioning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteUnited States
Study dates
28 Dec 2022to 10 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 45 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • aged 14-45 years
  • suffered an acute, complete ACL rupture
  • have undergone ACL reconstructive surgery
  • willingness to participate in testing and follow-up as outlined in the protocol

Who cannot join

  • have suffered a previous ACL injury on the contralateral leg
  • have undergone previous major surgery to the contralateral knee
  • have a history of recent significant knee injury (other than ACL) or lower-extremity fracture
  • have a history of uncontrolled diabetes or hypertension
  • be pregnant or plan to become pregnant
  • have metal implants in the head
Show all 10Show fewer
  • have electronic devices in their ear or heart (e.g., cochlear implants or cardiac pacemakers)
  • have unexplained recurrent headaches
  • have a recent history of seizure
  • have a history of repeated fainting spells

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Michigan

    Ann Arbor, Michigan, 48109

Other trials in United States

About this study

Official title: Conditioning Brain Responses for Modulating Corticospinal Excitability After ACL Reconstruction

The purpose of this study is to examine if the changes in corticospinal function that accompany ACL reconstruction can be improved through a form of mental coaching and encouragement, known as operant conditioning.

Read the detailed description

It is theorized reduced corticospinal excitability contributes to quadriceps dysfunction after knee injury and joint disease. Current rehabilitation does not directly target the alterations in corticospinal excitability, which may limit recovery. Operant conditioning is an emerging approach capable of increasing corticospinal excitability by directly targeting the corticospinal pathways. However, it remains to be determined whether operant conditioning of the corticospinal pathway may improve corticospinal function after knee trauma. Therefore, this study will evaluate the ability of operant up-conditioning of the corticospinal pathway to improve corticospinal function after ACL reconstruction.

Being tested
Operant Conditioning, Control
Keywords
ACL, Quadriceps
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Operant ConditioningBehavioural

    Active encouragement and feedback to increase motor evoked response during stimulation.

  • ControlBehavioural

    Absence of active encouragement and feedback to increase motor evoked response when stimulated.

Study groups in NCT05519345
Study groupRoleWhat they receive
Operant ConditioningExperimentalMotor evoked responses will be elicited along with operant conditioning training for about 2 weeks
Receives: Behavioral: Operant Conditioning
ControlExperimentalMotor evoked responses will be elicited without operant conditioning training for about 2 weeks
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in corticospinal excitability

    Corticospinal excitability will be measured using transcranial magnetic stimulation at baseline and post-intervention and will be compared between groups.

    Measured: Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2022
  2. Study start28 Dec 2022
  3. Primary completion10 Oct 2023
  4. Study completion10 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05519345
Sponsor's protocol ID
HUM00166442
Status last verified
Jan 2024
First submitted
17 Aug 2022
Last updated
23 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Operant Conditioning in people with Anterior Cruciate Ligament Injuries, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in corticospinal excitability (time frame: Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in